CFA Society of Houston Luncheon. February 22, 2017
|
|
- Pierce Terry
- 5 years ago
- Views:
Transcription
1 CFA Society of Houston Luncheon February 22, 2017
2 Forward Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included are statements relating to opening of new clinics, availability of personnel and reimbursement environment. The forward-looking statements are based on the Company s current views and assumptions and the Company s actual results could differ materially from those anticipated as a result of certain risks, uncertainties, and factors, which include, but are not limited to: general economic, business, and regulatory conditions; competition; reimbursement conditions; federal and state regulation; acquisitions; clinic closures, availability, terms, and use of capital; availability and cost of skilled physical and occupational therapists; and weather. 2 2
3 Investment Highlights Established Company 558 outpatient physical and occupational therapy clinics across 42 states 3rd largest owner/operator of clinics Only publicly-traded, pure play provider Attractive Market Dynamics US rehab market > $30B in annual revenue Highly fragmented; No company with >10% market share Favorable demographics aging and active population Proven Business Model Partner with experienced physical therapists Driven by organic growth and acquisitions Approximately 60% of clinics were de novo start-ups Solid Financial Position Diversified payor mix, only 24% of revs from Medicare Strong cash flow and balance sheet 3
4 National Footprint 4
5 Growth Strategy Drive organic growth through de novo PT/OT clinic openings, utilize true partnership model Maximize profits of existing facilities by growing patient volume; realize efficiencies through higher clinical productivity Augment organic growth through strategic acquisitions 5
6 Large and Growing Market Opportunity $30B+ U.S. rehab market with projected growth Favorable demographics physically active, aging and obese population segments Healthcare delivery shifting towards lower cost, high quality outpatient providers 6
7 Competitive Landscape Highly fragmented U.S. outpatient rehab market with ~16,000 18,000 clinics No company with >10% market share USPh ranks third nationally Select Medical/Physio 1615 Clinics ATI 600 Clinics USPh 558 Clinics Note: Owned Clinics 7
8 Focused Business Model Specialize in trauma, sports, work-related and pre and post surgical cases Partner with experienced physical therapists Drive volume via referrals Augment sales with marketing reps Historical focus on organic growth via lower cost de novo (start-up) clinics Strategic acquisitions structured like de novos as partnerships with significant ownership retained by founders 8
9 USPH Partnership Advantages Less Administrative Burden Accounting HR Real Estate Construction Purchasing Marketing Compliance Legal IT More Resources Access to Capital for Development of Additional Clinics No Personal Financial Risk Unlimited Earnings Potential Full Benefit Package Ongoing Guidance within Semi-Autonomous Work Environment 9
10 New Clinics / Brands 2016 as of 12/31/
11 Acquisition Strategy Completed 25 acquisitions since 2005 Range in size from 3 to 52 clinics Acquisition criteria: Owner therapists continue to operate clinics and retain significant equity interest Immediately accretive to earnings Further de novo growth opportunities 11
12 Executive Management Chris Reading Chief Executive Officer Joined USPh as COO in November 2003 Promoted to CEO and Board in November 2004 Previously Senior Vice President of Operations with HealthSouth, managed over 200 facilities including OP, ASC, DX Imaging and rehab hospital operations. BS Physical Therapy Larry McAfee Chief Financial Officer Joined USPh as CFO in September 2003 Promoted to EVP and Board in November 2004 Previously served as CFO and President of both public and private companies BBA & MBA Glenn McDowell Chief Operating Officer Joined USPh as Vice President - West Region in October 2003 Promoted to COO in January 2005 Previously Vice President of Operations with HealthSouth, managed 165 facilities including ASC, DX Imaging, OP and occupational medicine facilities. BS & Masters Physical Therapy 12
13 Diversified Payor Mix Percentage of 2016 Net Patient Revenue (Through September 30, 2016) 6% 17% 51% Private Insurance & Managed Care Medicare & Medicaid Workers Comp Other 26% 13
14 Worker s Comp Both internally and through acquisition, USPh has expanded its industrially focused worker s comp business. Approximately 17% of Company s patient revenue Treat, educate, assess and prevent work related injuries National approach with local care delivery, centralized scheduling-fast, easy and convenient. Services provided: job specific rehabilitation work hardening/conditioning physical work qualifications assessment post-offer pre-employment screening functional capacity evaluations ( FCE ) fitness programs ergonomic assessments onsite trainers and therapists 14
15 Strong Cash Flow and Balance Sheet Both de novo clinics and acquisitions financed primarily through free cash flow USPH trailing twelve months ended September 2016 adjusted EBITDA (1) of $54.6 million; an increase of 13.5% from the preceding twelve months (1) Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 15
16 Dividend In 2011 initiated quarterly dividend Increased dividend in 2012, 2013, 2014, 2015 and 2016 Paid special dividend in December 2012 Increased dividend in March 2016 by 13% Dividends do not impact ability to continue to grow internally through de novo clinic development and externally through acquisitions Dividend seen as additional way to increase returns to shareholders as Company is under leveraged and has excellent net free cash flow 16
17 Average Annual Rate of Return to Shareholders 37.8% Per Year *Current Management Team joined Company in Fall of 2003 and took over in late Total Cumulative Return through December, 2016 including dividends is $ Total Cumulative Return Percentage is 501.5%. Average Annual Return is 37.8%. Market Cap Increase during time period is from $154.7 million to $878.8 million or by $724.1 million or 468.1%. 17
18 10 Year Stock Performance (USPH Compared to Russell 2000) 18
19 Year Results December 31, 2014 December 31, 2015 Revenue $ M $ M 8.6% Gross Margin $ 76.2 M $ 78.4 M 2.9% Operating Income $ 45.8 M $ 47.3 M 3.3% Net Income $ 20.9 M $ 22.3 M 6.8% EPS $ 1.71 $ % Adjusted EBITDA* $ 46.3 M $ 50.3 M 8.7% Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 19
20 Nine Months Results September 2015 September 2016 Revenue $ M $ M 8.6% Gross Margin $ 56.9 M $ 63.2 M 11.2% Operating Income $ 34.7 M $ 38.6 M 11.2% Net Income $ 16.3 M $ 18.1 M 11.2% EPS $ 1.32 $ % Adjusted EBITDA $ 36.7 M $ 40.9 M 11.7% Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 20
21 Summary Only publicly-traded, pure play operator of rehab clinics Proven business model, driven by organic growth and acquisitions Significant scale with national footprint Large and growing market/favorable demographics Strong cash flow and balance sheet 21
22 Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA From Continuing Operations Nine Months Ended September 30 (amounts in 000 s) Net revenues $ 265,682 $ 244,578 Net Income attributable to U.S. Physical Therapy 18,112 16,288 Adjustments: Depreciation & amortization 6,210 5,656 Interest, net (income) / expense Equity grant expense 3,748 3,368 Provision for income taxes 11,975 10,634 Adjusted EBITDA $ 40,937 $ 36,663 Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 22
23 Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA Trailing Twelve Months Ended September 30 (amounts in 000 s) Net revenues $ 352,406 $ 323,968 Net Income attributable to U.S. Physical Therapy 24,103 21,265 Adjustments: Depreciation & amortization 8,506 7,714 Interest, net (income) / expense 1, Equity/grant expense 4,871 4,275 Provision for income taxes 15,994 13,875 Adjusted EBITDA $ 54,599 $ 48,097 Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, amortization and equity compensation expense. 23
24 NYSE: USPH
Company Declares Quarterly Dividend and Updates Earnings Guidance Reflecting Impact of Hurricanes Harvey and Irma
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 U.S. Physical Therapy Reports
More informationU.S. Physical Therapy Reports Record Earnings
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Westwicke Partners Bob East (443) 213-0502 U.S. Physical Therapy Reports
More informationU.S. Physical Therapy Reports Third Quarter Results
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Westwicke Partners Bob East (443) 213-0502 U.S. Physical Therapy Reports
More informationU.S. Physical Therapy Reports Year-End 2017 Earnings
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 U.S. Physical Therapy Reports
More informationU. S. Physical Therapy Reports First Quarter 2013 Results
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Stephanie Carrington The Ruth Group (646) 536-7017 U. S. Physical Therapy
More informationU. S. Physical Therapy Reports Second Quarter and Six Months Results
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Stephanie Carrington / Amy Glynn The Ruth Group (646) 536-7017 / 7023 U.
More informationU. S. Physical Therapy Reports Record Quarter and First Half Results
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Stephanie Carrington / Amy Glynn The Ruth Group (646) 536-7017 / 7023 U.
More informationU.S. Physical Therapy Reports Record Results and Raises 2014 Earnings Guidance
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Westwicke Partners Bob East (443) 213-0502 U.S. Physical Therapy Reports
More informationU. S. Physical Therapy Reports Results for First Quarter 2010
CONTACT: U.S. Physical Therapy, Inc. Larry McAfee, Chief Financial Officer Chris Reading, Chief Executive Officer (713) 297-7000 Stephanie Carrington / Amy Glynn The Ruth Group (646) 536-7017 / 7023 U.
More informationCorporate Presentation. November 2018
Corporate Presentation November 2018 1 Safe Harbor / Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time to time make, "forward-looking statements"
More informationFOR IMMEDIATE RELEASE. Genesis HealthCare Contact: Investor Relations GENESIS HEALTHCARE REPORTS FIRST QUARTER 2015 RESULTS
FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS FIRST QUARTER 2015 RESULTS Solid Quarter With Pro Forma 1 Adjusted: o EBITDAR of $185.4 Million
More informationSurgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference. January 2014
Surgical Care Affiliates, Inc. 32 nd Annual J.P. Morgan Healthcare Conference January 2014 Disclaimer Certain statements herein are forward-looking statements made pursuant to the safe harbor provisions
More informationU.S. PHYSICAL THERAPY, INC.
(MARK ONE) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD
More informationInvestor Presentation
Investor resentation Safe Harbor Disclosure All statements, other than statements of historical fact, made in this presentation and in any verbal statement provided in the course of this presentation regarding
More informationSUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012
SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012 MANAGEMENT S DISCUSSION AND ANALYSIS OF THE RESULTS OF OPERATIONS AND FINANCIAL POSITION SUMMA HEALTH
More informationJ.P. Morgan 35 th Annual Healthcare Conference. DRAFT 01/04/17 1p
J.P. Morgan 35 th Annual Healthcare Conference DRAFT 01/04/17 1p Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act
More informationQuarterly Report As of December 31, 2018 and for the three and six months ended December 31, 2018
Quarterly Report As of December 31, 2018 and for the three and six months ended December 31, 2018 Table of Contents Part I: Overview... 1 Part II: Leadership Changes... 1 Part III: Strategic Acquisitions...
More informationSelect Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2018
FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2018 MECHANICSBURG, PENNSYLVANIA
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO
J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations
More informationSelect Medical Holdings Corporation Announces Results for First Quarter Ended March 31, 2017
R E L E A S E FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results for First Quarter Ended March 31, 2017 MECHANICSBURG,
More informationInvestor Presentation. February 2012
Investor Presentation February 2012 Safe Harbor Some of the statements made in this presentation constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More information3 rd Quarter 2016 Webinar Series
3 rd Quarter 2016 Webinar Series Platform Advisor To Investment Programs Third Quarter 2016 Investor Presentation Important Information Risk Factors Investing in our common stock involves a high degree
More informationUTILIZATION AND PAYOR MIX
UTILIZATION AND PAYOR MIX Quarter Ended September 30 Year Ended September 30 2010 2011 2010 2011 Hospital Licensed Beds Average Staffed Beds Average Daily Census Average % Occupancy 284 70% 257 63% 285
More informationNovember Investor Presentation. ensigngroup.net
November 2018 Investor Presentation Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 Statements in this presentation concerning The Ensign Group s ( Ensign or the Company
More informationGENESIS HEALTHCARE ANNOUNCES PRELIMINARY 2016 GROWTH OUTLOOK AND ADJUSTS 2015 GUIDANCE
FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE ANNOUNCES PRELIMINARY 2016 GROWTH OUTLOOK AND ADJUSTS 2015 GUIDANCE KENNETT SQUARE, PA (January 25,
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY
More information37 th Annual J.P. Morgan Healthcare Conference January 9, 2019
37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
More informationBaird 2012 Healthcare Conference New York City September 6, Jay Grinney, President and Chief Executive Officer
Baird 2012 Healthcare Conference New York City September 6, 2012 Jay Grinney, President and Chief Executive Officer Forward-Looking Statements The information contained in this presentation includes certain
More informationSelect Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2018
. FOR IMMEDIATE RELEASE 4714 Gettysburg Road Mechanicsburg, PA 17055 NYSE Symbol: SEM Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2018 MECHANICSBURG, PENNSYLVANIA
More informationCompelling Strategic Transaction
ACQUISITION OF DJO GLOBAL November 19, 2018 Forward Looking Statements & Non-GAAP Disclaimer The following information may contain forward-looking statements, including forward-looking statements within
More informationnews FOR IMMEDIATE RELEASE
news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports Third Quarter 2018 Results Nashville, Tenn., October 30, 2018 HCA Healthcare,
More informationInvestor Presentation. January 2019
Investor Presentation January 2019 Forward Looking Statements and Non-GAAP Measures This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform
More informationHEALTHCARE TRUST, INC. 2 nd Quarter 2017 Investor Presentation
HEALTHCARE TRUST, INC. 2 nd Quarter 2017 Investor Presentation Important Information 2 Risk Factors For a discussion of the risks which should be considered in connection with our company, see the section
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Joe Woody Chief Executive Officer
J.P. MORGAN HEALTHCARE CONFERENCE Joe Woody Chief Executive Officer 0 OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and webcast, including our outlook, expectations and planning
More informationNasdaq: DVCR. Investor Update. As of September 30, 2017
Investor Update As of September 30, 2017 Forward-Looking Statements Nasdaq: DVCR Forward-looking statements made in this presentation involve a number of risks and uncertainties, but not limited to: the
More informationBIOSCRIP, INC. INVESTOR PRESENTATION June 2018 NASDAQ: BIOS THE LARGEST INDEPENDENT NATIONAL PROVIDER OF HOME INFUSION SOLUTIONS
BIOSCRIP, INC. INVESTOR PRESENTATION June 2018 NASDAQ: BIOS THE LARGEST INDEPENDENT NATIONAL PROVIDER OF HOME INFUSION SOLUTIONS DISCLAIMER Certain statements in this presentation and other oral or written
More informationBIOSCRIP, INC. INVESTOR PRESENTATION March 2018 NASDAQ: BIOS THE LARGEST INDEPENDENT NATIONAL PROVIDER OF HOME INFUSION SOLUTIONS
BIOSCRIP, INC. INVESTOR PRESENTATION March 2018 NASDAQ: BIOS THE LARGEST INDEPENDENT NATIONAL PROVIDER OF HOME INFUSION SOLUTIONS DISCLAIMER Certain statements in this presentation and other oral or written
More informationHEALTHCARE TRUST, INC. 3 rd Quarter 2017 Investor Presentation
HEALTHCARE TRUST, INC. 3 rd Quarter 2017 Investor Presentation Important Information 2 Risk Factors For a discussion of the risks which should be considered in connection with our company, see the section
More informationLINCARE HOLDINGS INC.
LINCARE HOLDINGS INC. Forward-Looking Statements Certain statements contained in this presentation constitute forward-looking statements. Such forwardlooking statements are based on management s current
More informationARA Investor Presentation Q3 2017
ARA Investor Presentation Q3 2017 Disclaimers Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended,
More informationMANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE
MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE Utilization Trends The Corporation has experienced an increase in utilization from the end of 2015 through fiscal year 2017. Occupancy of
More informationGenesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015
Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare
More informationCowen and Company 37 th Annual Health Care Conference. March 6, 2017
Cowen and Company 37 th Annual Health Care Conference March 6, 2017 Safe Harbor Statement and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements regarding
More informationUNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ALABAMA SOUTHERN DIVISION ) ) ) ) ) ) ) )
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ALABAMA SOUTHERN DIVISION In re HEALTHSOUTH CORPORATION SECURITIES LITIGATION This Document Relates To: ALL ACTIONS. ) ) ) ) ) ) ) ) Consolidated Case
More information35th Annual J.P. Morgan Healthcare Conference. January 12, 2017
35th Annual J.P. Morgan Healthcare Conference January 12, 2017 Safe Harbor Statement and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements regarding
More informationThe Ensign Group, Inc. (NASDAQ:ENSG)
The Ensign Group, Inc. (NASDAQ:ENSG) ENSG - Thesis Remains Intact; Reiterate MO MARKET OUTPERFORM COMPANY UPDATE Post Acute Care - Facilities February 14, 2013 Kevin Campbell, CFA, Managing Director kcampbell@avondalepartnersllc.com
More informationAlmost Family Reports Record Second Quarter 2008 Results
Almost Family, Inc. Steve Guenthner (502) 891-1000 The Ruth Group Investor Relations Stephanie Carrington / Jared Hoffman (646) 536-7017 / 7013 scarrington@theruthgroup.com jhoffman@theruthgroup.com Recent
More informationResults as of December 31, 2017
Results as of December 31, 2017 Safe Harbor and Regulation G Statement This presentation contains information about Chemed s EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and Adjusted
More informationNon-Profit/For-Profit Joint Ventures: Structuring & Valuing the Deal
Non-Profit/For-Profit Joint Ventures: Structuring & Valuing the Deal Hospitals and Health Systems Law Institute Elliott Jeter, CFA CPA/ABV VMG Health James Pinna, Esq Hunton & Williams LLP February 13,
More informationA leading provider of post acute services
A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More information4 th Quarter 2016 Webinar Series
4 th Quarter 2016 Webinar Series Platform Advisor To Investment Programs Fourth Quarter 2016 Investor Presentation Important Information Risk Factors Investing in our common stock involves a high degree
More informationINVESTOR PRESENTATION MAY 2017
INVESTOR PRESENTATION MAY 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking
More informationErie County Medical Center Corporation Operating and Capital Budgets. For the year ending 2018
Erie County Medical Center Corporation Operating and Capital Budgets For the year ending 2018 Table of Contents Page Management Discussion and Analysis 3-7 Regulatory Reporting Requirements 8 Budget Process
More informationPending Acquisition of Sleep Train. September 4, 2014
Pending Acquisition of Sleep Train September 4, 2014 Forward Looking Statements and Non-GAAP Information This presentation contains forward-looking statements within the meaning of federal securities laws,
More informationQ Complementary Summary of Omnicell Q Results: October 31, 2013
Q3 10-31-13 Complementary Summary of Omnicell Q3 Results: October 31, This complementary summary of Omnicell financial results includes forward-looking statements subject to risks, uncertainties and other
More informationU.S. PHYSICAL THERAPY, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment 1) (Mark One) È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE
More informationTenet Reports Second Quarter 2010 Results
åéïëêéäé~ëé Tenet Reports Second Quarter 2010 Results Diluted Earnings of $0.05 Per Share, Up from Loss of $0.03 Per Share Over Prior Year Period Net Income Attributable to Common Shareholders of $25 Million,
More informationCross Country Healthcare acquires Advantage RN
Cross Country Healthcare acquires Advantage RN Forward Looking Statements This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future
More information2018 J.P. Morgan Healthcare Conference. Mark Tarr, President and Chief Executive Officer January 9, 2018
2018 J.P. Morgan Healthcare Conference Mark Tarr, President and Chief Executive Officer January 9, 2018 Forward-Looking Statements The information contained in this presentation includes certain estimates,
More informationBIOSCRIP, INC. INVESTOR PRESENTATION December 2018 NASDAQ: BIOS THE LARGEST INDEPENDENT NATIONAL PROVIDER OF HOME INFUSION SOLUTIONS
BIOSCRIP, INC. INVESTOR PRESENTATION December 2018 NASDAQ: BIOS THE LARGEST INDEPENDENT NATIONAL PROVIDER OF HOME INFUSION SOLUTIONS DISCLAIMER Certain statements in this presentation and other oral or
More informationRadNet Reports First Quarter Financial Results
FOR IMMEDIATE RELEASE RadNet Reports First Quarter Financial Results Severe weather in the Northeast impacted Total Net Revenue ( Revenue ) by an estimated $5.9 million and Adjusted EBITDA (1) by $5.8
More informationHEALTHCARE HOSPITALITY
HEALTHCARE HOSPITALITY MEDICAL FACILITIES CORPORATION Fourth Quarter 2014 MANAGEMENT S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE-MONTH AND TWELVE-MONTH
More informationFactors in Physician Practice Valuation. May 2017
Factors in Physician Practice Valuation May 2017 Factors in Physician Practice Valuation Physician practice owners considering a sale may not have experience assessing the value of their practices in terms
More informationBank of America Leverage Finance Conference. November 29, 2016
Bank of America Leverage Finance Conference November 29, 2016 FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements that is, statements that relate to
More informationMEDICAL FACILITIES CORPORATION
MEDICAL FACILITIES CORPORATION June 2014 FORWARD LOOKING STATEMENTS This presentation may contain forward-looking statements within the meaning of certain securities laws, including the safe harbour provisions
More informationAnnual Shareholders Meeting. May 21, 2018
Annual Shareholders Meeting May 21, 2018 Safe Harbor and Regulation G Statement This presentation contains information about Chemed s EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and
More informationHow Do You Value Your ASC For Sale?
How Do You Value Your ASC For Sale? Vincent M. Kickirillo, CFA, AVA Partner VMG Health 2515 McKinney Avenue, Suite 1500 Dallas, Texas 75201 Telephone: 214.369.4888 Fax: 214.369.0541 3100 West End Avenue,
More informationSECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017
SECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017 SECOND QUARTER EARNINGS CALL AGENDA CEO Transition Robert Abernathy Chairman Strategic Vision Joe Woody Chief Executive Officer Second Quarter Results and
More informationInternational Paper Company. Reconciliation of Non-GAAP Financial Measures
International Paper Company Reconciliation of Non-GAAP Financial Measures This presentation includes certain non-u.s. GAAP financial measures. The calculation of these measures, and a reconciliation to
More informationGENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2015 RESULTS
FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2015 RESULTS KENNETT SQUARE, PA (February 22, 2016) Genesis
More informationU.S. PHYSICAL THERAPY, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD
More informationStrong Third Quarter Performance and Growth With Pro Forma 1 Adjusted: o o
FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 6109252000 GENESIS HEALTHCARE REPORTS THIRD QUARTER 2015 RESULTS Strong Third Quarter Performance and Growth With Pro Forma 1 Adjusted:
More informationHEALTHCARE TRUST, INC. 4 th Quarter 2017 Investor Presentation
HEALTHCARE TRUST, INC. 4 th Quarter 2017 Investor Presentation Important Information 2 Risk Factors For a discussion of the risks which should be considered in connection with our company, see the section
More informationGENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2017 RESULTS
Exhibit 99.1 FOR IMMEDIATE RELEASE Genesis HealthCare Contact: Investor Relations 610-925-2000 GENESIS HEALTHCARE REPORTS FOURTH QUARTER AND FISCAL YEAR END 2017 RESULTS KENNETT SQUARE, PA (March 16, 2018)
More informationInvestor Presentation April 2015
Investor Presentation April 2015 Forward-looking statements Certain statements included herein constitute forward looking statements within the meaning of the U.S. Private Securities Litigation Reform
More informationInvestor Update MARCH 2018
Investor Update MARCH 2018 TSX: DR Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of certain securities laws, including the safe harbour provisions
More informationThe Guthrie Clinic Financial Highlights for the Three and Six Months Ended December 31, 2017
Financial Highlights for the Three and Six Months Ended December 31, 2017 I. Introduction In accordance with the provisions of the Master Indenture relating to the 2011 and 2007 Guthrie Health Bonds, enclosed
More informationLHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017
LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare November 16, 2017 Forward-Looking Statements This presentation contains forward looking statements (as defined in the Securities
More informationINVESTOR UPDATE NOVEMBER 2017
INVESTOR UPDATE NOVEMBER 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking
More informationnews FOR IMMEDIATE RELEASE
news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports First Quarter 2018 Results Nashville, Tenn., May 1, 2018 HCA Healthcare, Inc.
More informationZimmer Biomet Reports Second Quarter 2017 Financial Results
Zimmer Biomet Reports Second Quarter 2017 Financial Results Jul 27, 2017 - Net sales of $1.954 billion for the second quarter represent an increase of 1.1% over the prior year period, and an increase of
More informationWILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL
WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL FORWARD LOOKING STATEMENT AND USE OF ADJUSTED MEASURES This presentation contains forward-looking statements including but not limited to
More informationInvestor Presentation. August 2007
Investor Presentation August 2007 Forward-Looking Statement This presentation should be considered forward-looking and is subject to various risk factors and uncertainties. For more information on those
More informationA leading provider of post acute services
A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits
More informationThe Ensign Group Reports Second Quarter 2009 Earnings of $0.39 per Share; Reaffirms 2009 EPS Guidance
The Ensign Group Reports Second Quarter 2009 Earnings of $0.39 per Share; Reaffirms 2009 EPS Guidance Conference Call and Webcast Scheduled for August 7, 2009 at 10:00 am PT MISSION VIEJO, Calif., Aug
More informationDJO Global, Inc. Company Presentation. June 2013
DJO Global, Inc. Company Presentation June 2013 Safe Harbor Statement This presentation has been prepared by DJOFL. The information contained in this presentation is for information purposes only. The
More informationBusiness Combination of Skyline Corporation and Champion Homes Creating the Nation s Largest Publicly Traded Factory-Built Housing Company
Business Combination of Skyline Corporation and Champion Homes Creating the Nation s Largest Publicly Traded Factory-Built Housing Company January 25, 2018 Disclaimer Forward-Looking Statements Statements
More informationSkilled Healthcare Group, Inc + Genesis HealthCare LLC
Skilled Healthcare Group, Inc + Genesis HealthCare LLC Creating a Leading National Provider of Post-Acute Services November 2014 Safe Harbor Statement Certain statements in this presentation regarding
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationForward-Looking Statements
Forward-Looking Statements The information contained in this presentation includes certain estimates, projections and other forward-looking information that reflect HealthSouth s current outlook, views
More informationFOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationBank of America Merrill Lynch 2018 Leveraged Finance Conference December 4, 2018
Bank of America Merrill Lynch 2018 Leveraged Finance Conference December 4, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the
More informationHEALTHSOUTH CORP FORM 10-Q. (Quarterly Report) Filed 07/29/14 for the Period Ending 06/30/14
HEALTHSOUTH CORP FORM 10-Q (Quarterly Report) Filed 07/29/14 for the Period Ending 06/30/14 Address 3660 GRANDVIEW PARKWAY SUITE 200 BIRMINGHAM, AL 35243 Telephone 205-967-7116 CIK 0000785161 Symbol HLS
More informationWill Health Plans Kill the Laboratory Outreach Program?
Will Health Plans Kill the Laboratory Outreach Program? Jane M. Hermansen MBA, MT(ASCP) Mayo Clinic Rochester, Minnesota Learning Objectives Describe emerging payer trends in today s healthcare environment
More informationThe Future of Healthcare from a Public Health System Perspective. George V. Masi President and Chief Executive Officer
The Future of Healthcare from a Public Health System Perspective George V. Masi President and Chief Executive Officer Mission: We improve our community s health by delivering high-quality healthcare to
More informationMulti-Color Corporation Investor Update
Multi-Color Corporation Investor Update November 2018 Nasdaq: LABL www.mcclabel.com Safe Harbor Statement SAFE HARBOR STATEMENT The Company believes certain statements contained in this report that are
More informationAnnual Report For the Period Ending 6/30/12
This Document is Dated as of November 1, 2012. SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS: Certain of the discussions included in the Management Discussion and Analysis section of the following
More informationMANAGEMENT S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2018
MANAGEMENT S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2018 May 9, 2018 The following Management s Discussion and Analysis
More informationQuarterly Results Presentation
Quarterly Results Presentation Third Quarter of 2016 October 31, 2016 FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements that is, statements that relate
More informationTenet Reports Results for the Third Quarter Ended September 30, 2018
Tenet Reports Results for the Third Quarter Ended September 30, 2018 Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $9 million or $0.09 per diluted share
More information